Research News

David Diemert, M.D., associate professor of microbiology, immunology, and tropical medicine, and Jeffrey Bethony, Ph.D., professor of microbiology, immunology, and tropical medicine, received a $2.2 million grant from the National Institutes of Health to work on a phase 1 clinical trial to test…
GW researcher and dermatologist, Adam Friedman, M.D., and colleagues, find that the release of nitric oxide over time may be a new way to treat and prevent acne through nanotechnology.
Researchers at the George Washington University (GW), led by Michael S. Irwig, M.D., found that men referred for tertiary care for borderline testosterone levels had much higher rates of depression and depressive symptoms than those of the general population.
The GW School of Medicine and Health Sciences, the GW University Hospital, and the GW Medical Faculty Associates are pleased to announce the appointment of Eduardo M. Sotomayor, M.D., who will serve as the inaugural director of the GW Cancer Center. As director, Sotomayor will establish the GW…
Brad Jones, assistant professor of microbiology, immunology, and tropical medicine, received a $180,000 grant from amfAR's generationCURE for his research looking at whether a novel combination therapy can eradicate the latent reservoirs of HIV that present a major barrier to finding a cure.
Researchers at Children's National Health System, a clinical partner of the GW School of Medicine and Health Sciences, joining other teams, have uncovered new evidence that T-cells, a type of blood cells, can effectively restore antiviral immunity after transplantation for some of the most high-…
An interdisciplinary, city-wide consortium of researchers, led by Alan E. Greenberg, MD, MPH, professor and chair in the Department of Epidemiology and Biostatistics at Milken Institute School of Public Health, has received a grant from the National Institutes of Health for an expected $7.5 million…
Larrissa May, M.D., director of the Clinical Research Fellowship and associate professor in the Department of Emergency Medicine, was published in Clinical Infectious Disease for her research finding a rise in shortages of key antibiotics used to treat highly resistant infections.
New research published in Nature has found several drugs could lead to new treatment options for multiple sclerosis (MS), including two drugs that effectively treat MS at the source, in vivo. When administered at the peak of disease, these two drugs showed a striking reversal of disease severity.
More than 280 posters highlighting basic science research projects to translational efforts were presented at Health and Medicine Research Day.